Back
Akari Therapeutics PLC Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
AKTX
Akari Therapeutics PLC
Last Price:
$1.12
Seasonality Move:
22.09%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing slight buying pressure.
Akari Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.12 | Sell |
| 20-day SMA: | 1.14 | Sell |
| 50-day SMA: | 1.24 | Sell |
| 200-day SMA: | 1.45 | Sell |
| 8-day EMA: | 1.12 | Sell |
| 20-day EMA: | 1.15 | Sell |
| 50-day EMA: | 1.2 | Sell |
| 200-day EMA: | 1.55 | Sell |
Akari Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 41.79 | Sell |
| Chaikin Money Flow: | 42 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.11 - 1.19) | Sell |
| Bollinger Bands (100): | (1.04 - 1.36) | Sell |
Akari Therapeutics PLC Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akari Therapeutics PLC Stock
Is Akari Therapeutics PLC Stock a Buy?
-
Akari Therapeutics PLC share price is 1.11 while AKTX 8-day simple moving average is 1.12, which is a Sell signal.
-
The stock price of AKTX is 1.11 while Akari Therapeutics PLC 20-day SMA is 1.14, which makes it a Sell.
-
Akari Therapeutics PLC 50-day simple moving average is 1.24 while AKTX share price is 1.11, making it a Sell technically.
-
AKTX stock price is 1.11 and Akari Therapeutics PLC 200-day simple moving average is 1.45, creating a Sell signal.
AKTX Technical Analysis vs Fundamental Analysis
Sell
33
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy or a Sell?
-
Akari Therapeutics PLC stock is rated a SellThe current Akari Therapeutics PLC [AKTX] share price is $1.11. The Score for AKTX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Akari Therapeutics PLC Stock Info
Market Cap:
35.7M
Price in USD:
1.11
Share Volume:
16.9K
Akari Therapeutics PLC 52-Week Range
52-Week High:
4.40
52-Week Low:
0.85
Sell
33
Akari Therapeutics PLC (AKTX)
is a Sell
Akari Therapeutics PLC Share Price Forecast
-
What is the Akari Therapeutics PLC stock price today?The Akari Therapeutics PLC stock price is 1.11 USD today.
-
Will AKTX stock go up or go down?Akari Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Akari Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akari Therapeutics PLC is overvalued.
Is Akari Therapeutics PLC Stock a Buy?
-
Akari Therapeutics PLC share price is 1.11 while AKTX 8-day exponential moving average is 1.12, which is a Sell signal.
-
The stock price of AKTX is 1.11 while Akari Therapeutics PLC 20-day EMA is 1.15, which makes it a Sell.
-
Akari Therapeutics PLC 50-day exponential moving average is 1.20 while AKTX share price is 1.11, making it a Sell technically.
-
AKTX stock price is 1.11 and Akari Therapeutics PLC 200-day simple moving average is 1.55, creating a Sell signal.
Fundamental Analysis of Akari Therapeutics PLC
Is Akari Therapeutics PLC a good investment?
-
Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.95 per share, and an increase next year of $0.05 per share.
Technical Analysis of Akari Therapeutics PLC
Should I short Akari Therapeutics PLC stock?
-
AKTX Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Akari Therapeutics PLC is a Sell
-
Akari Therapeutics PLC Relative Strength Index (RSI) is 41.79, which suggest Akari Therapeutics PLC is oversold
-
The Bollinger Bands (25) for Akari Therapeutics PLC is (1.11 - 1.19), which suggest Akari Therapeutics PLC is a Sell
-
The Bollinger Bands (100) for Akari Therapeutics PLC is (1.04 - 1.36), which suggest Akari Therapeutics PLC is a Sell
* Akari Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.